Loading...

CVM CEL SCI CORP Capital Structure Changes 8-K Filing

CL S

CVM

CEL SCI CORP

(CVM)

2025 8-K

Strategic Partnership

Stock Offering Announcement

Shareholder Rights Update

Rights Agreement Update

Stock Offering Details

New Drug Partnership

Equity Offerings

Equity Offerings

Management Change

Leadership Appointment

Placement Agency Agreement

Positive Results from Bias ...

Conference Presentation

Appointment of Mario Gobbo ...

Annual Meeting Results

Entry into Material Definit...

Entry into Material Definit...

Extension of Employment Agr...

Extension of Employment Agr...

Equity Offerings

Equity Offerings

Filing Letter with Quantita...

Underwriting Agreement

External Links:

CEL-SCI Corporation announced a Placement Agency Agreement on July 11, 2025, to sell 1.5 million shares at $3.82 each, aiming for approximately $5.73 million in proceeds to support its Multikine development and general corporate purposes. The offering closed on July 14, 2025.

AI Assistant

CEL SCI CORP

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.